Veregen sinecatechins regulatory update

Medigene said Taiwan approved Veregen sinecatechins ointment to treat external genital warts. Medigene expects the SynCore Biotechnology Co. Ltd. subsidiary of Sinphar Pharmaceutical Co. Ltd. (Taiwan:1734, Taipei City, Taiwan) to launch the product in Taiwan next half. SynCore has exclusive rights to commercialize the product from Medigene in Taiwan, Australia, New Zealand and Asia, excluding China and Korea (see BioCentury, March 25). ...